TORONTO, July 17 /CNW/ - Amorfix Life Sciences (TSX-V: AMF), a company
focused on diagnostics and treatments for brain wasting diseases today
announced that the common shares of the Company have been conditionally
approved for listing on the Toronto Stock Exchange (TSX). Amorfix is currently
listed on the TSX Venture Exchange.
